A New FDA "ban"

Why the FDA Reclassified 17 Peptides — and What It Really Means”

💬 Episode Description

The headlines said the FDA “banned 17 peptides.” But the truth? It’s not a sudden ban — it’s the inevitable fallout of peptides becoming too popular for their own good.

In this episode, Joanne Lee Cornish breaks down what really happened in July, why it started with the GLP-1 explosion, and how the FDA’s new classification is reshaping the peptide world. From BPC-157 to MOTs-C and Epitalon, we’ll explore what each of the 17 peptides was known for, why compounding pharmacies can’t touch them anymore, and why large-scale human trials are still a distant dream.

Joanne also dives into the biggest roadblocks — why most peptides can’t be patented, and why that makes them a direct threat to multi-billion-dollar pharmaceuticals. The result? They’re too natural to own, too effective to ignore, and too competitive for Big Pharma to tolerate.

If you’re curious about where the peptide world stands now — what’s still available, what to be cautious about, and how this all ties back to the booming GLP-1 market — this 20-minute episode will bring it all together.

🧠 In This Episode

• What really happened in July: the FDA’s reclassification of 17 peptides

• Why GLP-1 drugs like semaglutide and tirzepatide triggered the crackdown

• A simple breakdown of what each peptide is used for — from gut repair to muscle growth

• How the FDA’s approval process really works (and why it costs millions)

• The two biggest barriers to legitimizing peptides: 1️⃣ You can’t patent what nature already makes 2️⃣ They compete directly with blockbuster drugs

• Why Big Pharma has zero incentive to fund peptide trials

• The gray zone: peptides still available through research labs — and how to approach them cautiously

⚡ Key Takeaway

Peptides didn’t suddenly become unsafe — they became too popular. And when something natural threatens a billion-dollar industry, regulation always follows.

🔗 Mentioned in This Episode

Learn more about the peptides discussed in this episode and the science behind them:

• 5-Amino-1MQ – a breakthrough compound supporting muscle preservation and metabolic health: www.5amino.com

• SLU-PP-332 – designed to enhance cellular energy and performance: www.slu332.com

🎧 Listen & Subscribe

🎙️ Midlife Mayhem is available on all major platforms. Subscribe, share, and leave a review if you enjoyed this deep dive into the science, politics, and reality of modern health optimization.